Slb Pharma Private Limited - Charges

Every charge - open or closed - that lenders have registered against Slb Pharma Private Limited, with the most recent activity at the top.

2007-03-05 Patancheru Mandal, Telangana Active Unlisted Active Compliant
Share
Connect MCP
SP Slb Pharma Private Limited
Open charges
4
4.26 cr
Closed charges
0
0.00
Total
4
4.26 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Bank Of India 4 4.26 cr
All charges (4) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
100909391 Bank Of India 02 May 2024 - - 2.00 cr Open
100839072 Bank Of India 03 Jan 2024 - - 19.00 Lakh Open
100839074 Bank Of India 03 Jan 2024 - - 10.00 Lakh Open
10294848 Bank Of India 06 May 2010 10 Aug 2017 - 1.97 cr Open
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Slb Pharma Private Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Slb Pharma Private Limited (CIN: U24232TG2007PTC053031). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Slb Pharma Private Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.